Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -70.00% vs 25.00% in Mar 2024
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 373.63% vs -39.20% in Mar 2024
Compare Balance Sheet Results of Biogen Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
65.26
13.54
51.72
381.98%
Share Warrants & Outstandings
Total Reserve
-9.03
-1.60
-7.43
-464.38%
Shareholder's Funds
91.93
14.68
77.25
526.23%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
2.54
-2.54
-100.00%
Secured Loans
0
0.00
0.00
0.00%
Unsecured Loans
0
2.54
-2.54
-100.00%
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00%
Other Long Term Liabilities
0.09
0.00
0.09
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
2.54
-2.54
-100.00%
Current Liabilities
Trade Payables
0.00
0.02
-0.02
-100.00%
Other Current Liabilities
0.00
0.16
-0.16
-100.00%
Short Term Borrowings
0.00
0.06
-0.06
-100.00%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
0.18
0.24
-0.06
-25.00%
Total Liabilities
92.02
17.45
74.57
427.34%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.00
0.00
0.00
0.00%
Less: Accumulated Depreciation
0.00
0.00
0.00
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
0.00
0.00
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0
8.91
-8.91
-100.00%
Long Term Loans & Advances
65.50
0.00
65.50
0.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
0.57
8.91
-8.34
-93.60%
Current Assets Loans & Advances
Current Investments
23.84
0.00
23.84
0.00%
Inventories
0.00
0.00
0.00
0.00%
Sundry Debtors
0.00
0.14
-0.14
-100.00%
Cash and Bank
2.02
4.11
-2.09
-50.85%
Other Current Assets
0
0.00
0.00
0.00%
Short Term Loans and Advances
0.00
4.29
-4.29
-100.00%
Total Current Assets
25.86
8.54
17.32
202.81%
Net Current Assets (Including Current Investments)
25.68
8.30
17.38
209.40%
Total Current Assets Excluding Current Investments
2.02
8.54
-6.52
-76.35%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
92.02
17.45
74.57
427.34%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
2.60
-2.60
-100.00%
Book Value per share (adjusted)
0.86
8.82
-7.96
-90.25%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -70.00% vs 25.00% in Mar 2024
Annual - Fixed Assets
No Fixed Assets in the last few periods
No Fixed Assets in the last few periods;
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 25.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 373.63% vs -39.20% in Mar 2024
